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Abstract: Purpose
To estimate the probability of ≥50% coronary stenoses based on computed
tomography (CT) segmental calcium score (SCS) and clinical factors.
Materials and Methods
The Institutional Review Board approved the study. A training sample of 201 patients
underwent CT calcium scoring and conventional coronary angiography (CCA). All
patients consented to undergo CT before CCA after being informed of the additional
radiation dose. SCS and calcification morphology were assessed in individual coronary
segments. We explored the predictive value of patient's symptoms, clinical history,
SCS and calcification morphology. We developed a prediction model in the training
sample based on these variables then tested it in an independent test sample.
Results
The odds ratio (OR) for ≥50% coronary stenosis was 1.8-fold greater (p = 0.006) in
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
patients with typical chest pain, 2-fold (p = 0.014) greater in patients with acute
coronary syndromes, 2-fold greater (p <0.001) in patients with prior myocardial
infarction. Spotty calcifications had an OR for ≥50% stenosis 2.3-fold (p <0.001)
greater than the absence of calcifications, wide calcifications 2.7-fold (p <0.001)
greater, diffuse calcifications 4.6-fold (p <0.001) greater. In middle segments, each unit
of SCS had an OR 1.2-fold (p <0.001) greater than in distal segments; in proximal
segments the OR was 1.1-fold greater (p = 0.021). The ROC curve area of the
prediction model was 0.795 (0.95 confidence interval: 0.602-0.843). Validation in a test
sample of 201 independent patients showed consistent diagnostic performance.
Conclusion
In conjunction with calcification morphology, anatomical location, patient's symptoms
and clinical history, SCS can be helpful to estimate the probability of ≥50% coronary
stenosis.
Response to Reviewers: COMMENTS FOR THE AUTHOR
* and Point-to-point responses *
Reviewer #1: The authors have conducted a detailed analysis of a novel evaluation of
non-contrast computed tomographic coronary calcium. They use their novel segmental
coronary calcium score in a cross-sectional study in a prediction model for odds ratio of
stenosis.
Comment #1: The concept is not entirely novel as there have been many groups that
have
reported a variety of methods to go beyond the Agatston-Janowitz calcium score. The
challenge is that so many work stations have the AJ score already in place, and there
is an abundance of literature behind the AJ score already. So there is a heavy inertia to
overcome which would require something really useful.
* We agree with this reviewer that the Agatston score is the most widely used clinically,
which is probably backed by vast prognostic data obtained decades ago. We used
here however a segmental Agatston score, to evaluate if the “local” quantity of
calcification can help interpret coronary CTA, when coronary CTA interpretation is
limited by a visual effect known as the “blooming effect”. *
Comment #2: While the methods are detailed and interesting and the score does
predict stenosis, ultimately a symptomatic patient will just get a CTA to evaluate non-
calcified and calcified plaque.
* We fully agree with this reviewer. However the interpretation of coronary CTA in
heavily calcified vessels may be challenging. We hypothesized that segmental calcium
score may be an aid to coronary CTA interpretation when the latter is difficult to
interpret due to bulky calcifications. We are not proposing to replace coronary CTA with
segmental calcium score. *
Comment #3: The manuscript is lengthy and could be condensed in the discussion.
In spite of these conceptual limitations, the study is interesting with a sound design and
analysis.
* We have shortened the Discussion and removed the Appendix from the manuscript,
as recommended by this reviewer and by the Editors. *
Reviewer #3: This is an attempt to build a multivariable model to predict significant
stenosis in particular coronary artery segments using segmental calcium score and a
variety of clinical parameters. It is exemplary in its use of a large dataset, appropriately
split into training and test sets, and in the methods used to construct the model, for
example, the use of GEE to derive the prediction model, given that the variables
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
selected likely have a high degree of interdependence. I also liked the fact that the gold
standard was catheter angiography rather than CCTA.
Comment #1: I do have doubts as to the clinical utility of this approach, however. In our
practice, and in the practice at other institutions with which I am familiar, calcium
scoring is simply not used in the acute setting. In an intermediate-risk acute patient,
CCTA with calcium scoring may be employed, but in this situation, any patient with a
difficult-to-quantitate heavily calcified lesion is going catheter angiography, and this
prediction model would not be helpful here. In non-acute patients getting calcium
scoring for risk assessment, again it is hard to imagine how this model might be used,
perhaps only in very select circumstances to direct additional testing in intermediate-
risk patients who are flagged as "high-risk" by use of this model. Regardless, I think
this paper should be published for two reasons. First, I think it is a model paper
demonstrating how prediction models of this type should be constructed and
evaluated. I have seen too many papers of this type over the years with severe
methodologic flaws, so it's nice to see one properly done. Second, I enjoyed the
authors discussion and in particular, the "future developments" section. The authors'
thoughts here will be very helpful providing ideas for future work.
* We thank this reviewer for his/her kind and constructive comments.
- 1. We have mentioned and referenced in our Discussion the ability to obtain calcium
score from coronary CTA, by using either subtraction approaches or dual-energy
protocols, without performing an additional pre-contrast scan. This could in principle
overcome the issue of patients not routinely receiving non-contrast scans prior to
coronary CTA, as mentioned by the reviewer.
- 2. In stable, intermediate risk patients, we agree that some practices may prefer to
refer to invasive angiography cases where calcified lesions challenge the interpretation
of coronary CTA. However, this is likely to lead to a number of unnecessary invasive
procedures. Once the coronary CTA has been acquired, we should try to maximize its
diagnostic yield both to diagnose and rule-out clinically relevant lesions. Strategies to
reduce falsely positive findings on coronary CTA should be sought. Whilst we have
discussed new approaches (FFRCT, perfusion imaging etc.) in our Discussion, we
describe in our manuscript an approach that uses existing non-contrast calcium score
data (which are still part of the standard clinical protocol at most institutions) and
clinical data, without additional time-intensive post-processing (e.g. FFRCT) and
without additional imaging, radiation, contrast and/or pharmacological stress (e.g.
perfusion imaging). *
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Abbreviations 
 
CT = computed tomography 
SCS = segmental calcium score 
CCTA = coronary computed tomography angiography 
CCA = conventional coronary angiography 
OR = odds ratio 
CI = confidence interval 
ROC = receiver operating characteristic 
AUC = area under the curve 
EBT = electron-beam tomography 
bpm = beats per minute 
ECG = electrocardiogram 
AHA = American Heart Association 
QCA = quantitative coronary angiography 
RCA = right coronary artery 
LAD = left anterior descending coronary artery 
LCx = left circumflex artery 
LM = left main trunk 
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Abstract  
 
Purpose 
To estimate the probability of ≥50% coronary stenoses based on computed tomography (CT) 
segmental calcium score (SCS) and clinical factors. 
 
Materials and Methods  
The Institutional Review Board approved the study. A training sample of 201 patients underwent 
CT calcium scoring and conventional coronary angiography (CCA). All patients consented to 
undergo CT before CCA after being informed of the additional radiation dose. SCS and 
calcification morphology were assessed in individual coronary segments. We explored the 
predictive value of patient’s symptoms, clinical history, SCS and calcification morphology. We 
developed a prediction model in the training sample based on these variables then tested it in an 
independent test sample.  
 
Results  
The odds ratio (OR) for ≥50% coronary stenosis was 1.8-fold greater (p = 0.006) in patients with 
typical chest pain, 2-fold (p = 0.014) greater in patients with acute coronary syndromes, 2-fold 
greater (p <0.001) in patients with prior myocardial infarction. Spotty calcifications had an OR for 
≥50% stenosis 2.3-fold (p <0.001) greater than the absence of calcifications, wide calcifications 
2.7-fold (p <0.001) greater, diffuse calcifications 4.6-fold (p <0.001) greater. In middle segments, 
each unit of SCS had an OR 1.2-fold (p <0.001) greater than in distal segments; in proximal 
segments the OR was 1.1-fold greater (p = 0.021). The ROC curve area of the prediction model 
was 0.795 (0.95 confidence interval: 0.602-0.843). Validation in a test sample of 201 independent 
patients showed consistent diagnostic performance. 
 
Conclusion 
In conjunction with calcification morphology, anatomical location, patient’s symptoms and clinical 
history, SCS can be helpful to estimate the probability of ≥50% coronary stenosis.  
 
Keywords 
computed tomography; 
coronary computed tomography angiography;  
coronary calcification; atherosclerosis; 
coronary arteries.
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Introduction 
 
The total amount of coronary artery calcification quantified by electron beam tomography or more 
recently by multidetector computed tomography (CT) correlates with the probability of 
angiographically significant (≥50% diameter reduction) stenosis at the patient level (1-4). A calcium 
score of 0 indicates a low probability of ≥50% coronary stenosis (1). A calcium score ≥400 
indicates a relatively high probability of ≥50% coronary stenosis in patients ≥50 years old anywhere 
in the coronary tree. This information is not site-specific. The total calcium score does not provide 
information regarding the probability of stenosis at the level of a specific coronary segment or 
lesion. Moreover, the relationship between intermediate values of calcium score (e.g., between 1 
and 399) and associated stenosis is weak. Contrast-enhanced coronary CT angiography (CCTA) 
can overcome the known diagnostic limitations of calcium score. Unfortunately though, bulky 
calcifications may hinder the visualization of the coronary lumen at CCTA (“blooming effect”), thus 
the evaluation of stenosis severity in calcified vessels can be challenging.  
The purpose of this study was to develop an algorithm for estimating the probability ≥50% coronary 
stenoses based on CT segmental calcium score (SCS) and clinical factors. The algorithm consists 
of a multivariable prediction model that includes the SCS measured in a given coronary segment, 
the patient’s symptoms and clinical history to calculate the probability of ≥50% coronary artery 
stenosis in the same coronary segment. 
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Materials and Methods 
 
Patients  
 
The Institutional Review Board approved the study protocol. All patients consented to undergo CT 
before CCA after being informed of the additional radiation dose. They also consented on the use 
of their data for retrospective research.  
During a 24-month period, 402 patients with stable or acute chest pain were recruited to an 
ongoing study (5) comparing 64-detector row CCTA with conventional coronary angiography 
(CCA). Patients in sinus heart rhythm, able to hold their breath for 15 seconds and without 
previous coronary revascularization were included. Impaired renal function (serum creatinine >120 
µmol/L) and known contrast allergy were exclusion criteria.  
 
Preparation and coronary calcium scans 
 
Patients with heart rates >65 beats per minute (bpm) received 100 mg metoprolol orally 1 hour 
before the scan. Scans were performed with a 64-detector row CT scanner with a gantry rotation 
time of 330 ms, a temporal resolution of 165 ms and a spatial resolution of 0.4 mm3 (Somatom 
Sensation 64; Siemens, Forchheim, Erlangen, Germany).  
The non-enhanced coronary calcium scans were acquired with a standard spiral low-dose protocol 
using ECG-gating. Scan parameters were as follows: 32*2 slices per rotation with z-flying focal 
spot technology, providing 64 slices/rotation; 0.6 mm individual detector width, 330 ms rotation 
time, 3.8 mm/rotation table feed, 19.2mm beam width, 11.5mm/s table speed, 120 kV tube voltage, 
150 mAs tube current, with activated prospective x-ray tube modulation. Overlapping slices were 
reconstructed at 65% of the R-R interval (retrospective ECG-gating) using B35f convolution kernel. 
Reconstructed slice thickness was 3.0 mm with an increment of 1.5 mm. The radiation exposure, 
estimated using dedicated software (ImPACT, version 0.99x, St. George’s Hospital, Tooting, 
London, United Kingdom), was 1.4 mSv in men and 1.8 mSv in women. 
 
Computed tomography coronary angiography (CCTA) scans 
 
For the contrast-enhanced CCTA studies, 80 ml of contrast agent (iomeprol; Iomeron, 400 mg/ml; 
Bracco, Milan, Italy) were injected intravenously into an antecubital vein. The injection rate was 5 
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ml/s. A bolus-tracking technique was used to time the scan (5-7). Scan parameters were identical 
to those used for coronary calcium scanning except for a tube current of 900mAs. Datasets were 
reconstructed using retrospective ECG gating and a mono-segmental reconstruction algorithm (5-
7). Overlapping slices were reconstructed at 65% of the R-R interval (retrospective ECG-gating) 
using a medium-smooth convolution kernel. Reconstructed slice thickness was 0.75 mm with an 
increment of 0.4 mm. The estimated radiation exposure was 14.2 mSv in men and 18.4 mSv in 
women, in keeping with estimated X-ray radiation exposure values reported using similar CT 
technology (64-slice) and scan protocol (retrospective ECG-gating) (8). 
 
Conventional coronary angiography (CCA) 
 
CT and CCA were carried out within a time interval of 1 week. A single observer (>10-year 
experience) identified coronary segments on CCA following a 17-segment modified American 
Heart Association (AHA) classification model (9). Coronary stenoses with diameter reduction 50% 
were identified using validated quantitative coronary angiography (QCA) software (CAAS II®, Pie 
Medical, Maastricht, the Netherlands).  
 
Analysis of segmental calcium score (SCS) and calcification morphology  
 
CT datasets were analyzed using an off-line workstation (syngo MultiModality Workplace VE25A, 
Siemens, Erlangen, Germany). Dedicated software (syngo Calcium Scoring VE31H, Siemens, 
Germany) was used for measuring calcium score in non-enhanced scans (10). One experienced 
observer, unaware of the CCA results, measured segmental calcium scores (SCS) in individual 
coronary segments using a standard technique based on seed points and a region-growing 
algorithm. Results were expressed using the Agatston (11), volume (12) and mass (13) scores. 
The analysis is described in detail in Figure 1 and Figure 2. As shown in Figure 3, calcification 
morphology in each segment was classified as spotty, wide or diffuse based on the width and 
length of the calcification in relation to the coronary segment diameter, following a validated 
classification model previously described by Kajinami et al. (14) (Table 1). In the event of multiple 
calcifications with different morphology within the same segment, the segment was classified as 
the calcification with the largest size.  
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In this study the outcome of interest was 50% diameter stenosis as demonstrated by the gold 
standard invasive CCA. CCTA was used exclusively for the anatomical classification of coronary 
segments, but not for grading lesion severity. The evaluation of the diagnostic performance of 
CCTA in the identification of coronary stenosis compared to CCA was reported previously (ref. 
blinded for review) and was beyond the purpose of this study. 
 
Statistical analysis  
 
Statistical analysis was performed using commercially available software (IBM SPSS, version 20, 
Chicago, IL, and STATA/SE 10.0, College Station, TX). Quantitative variables were expressed as 
means (standard deviations) and categorical variables were expressed as frequencies or 
percentages. The definitions of variables such as symptoms and risk factors are given in Table 2. 
The level of significance was chosen at a p-value <0.05.  
 
Data from 402 patients were split into two equal-sized datasets. One dataset containing 201 
patients was used to derive the multivariable prediction model (training set) and the remaining 201 
patients were used to validate the prediction model (test set). Baseline characteristics were 
compared between two sets (Table 2). Continuous variables were tested using Mann-Whitney U 
test and categorical variables were compared with the chi-squared statistic.   
 
In the training set, we identified highly correlated variables, explored the predictive value of the 
variables and derived a multivariable prediction model. There was high correlation between the 
Agatston and the volume scores (Pearson r = 0.990; p <0.001), the Agatston and the mass scores 
(r = 0.995; p <0.001) and the volume and the mass scores (r = 0.989; p <0.001). We used the 
Agatston score for further analyses because it has been extensively validated in clinical practice 
(1-4, 11). In the training set, we determined the frequency of the outcome of interest i.e. 50% 
stenoses at the segment level according to ranges of SCS and calcification morphology. Stenoses 
with a diameter narrowing ≥50% at CCA were defined as the reference standard to define positive 
cases. This is in accordance to the definition of ‘significant’ stenosis most widely used in cardiac 
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CT literature. The natural log transforms of (SCS + 1) were used because SCS showed a skewed 
distribution.  
 
We performed univariable analyses to evaluate the significance of SCS in each segment, 
calcification morphology, segment location (proximal, middle, and distal/side branches, as 
previously described (15)), major coronary vessel (RCA, LAD, LCx, LM), age, gender, patient’s 
symptoms (typical chest pain/atypical chest pain/acute coronary syndrome), risk factors (obesity, 
hypertension, smoking, diabetes mellitus, hypercholesterolemia, family history of premature 
coronary artery disease) and clinical history (prior myocardial infarction) for the prediction of 50% 
stenosis. Variables with a p-value <0.10 in the univariable analyses were entered in the 
multivariable model. Interaction terms were explored between morphology and SCS, location and 
SCS, location and morphology, vessel and SCS, and vessel and morphology. The final 
multivariable model included all variables with a p-value <0.05 and variables with a p-value <0.10 
that were considered to be important based on clinical judgment and internal consistency of the 
model. Odds ratios (OR) and robust 95% confidence intervals (CI) are reported.  
 
Generalized estimating equations (GEE) with binomial family, logit link function, exchangeable 
correlation matrix, and robust –sandwich– standard errors was applied to drive the prediction 
model on the training set. This took into account of the clustering feature that each patient had 
multiple segments measured. Receiver-operating characteristic (ROC) curve with area under the 
curve (AUC) was used to access the performance of the prediction model.  The derived prediction 
model was then validated by the test set. 
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Results 
 
Baseline characteristics and angiographic findings (Table 2) 
 
In the training set, 126/201 (62.7%) patients had at least one ≥50% stenosis (Table 2). A total of 
3001 coronary segments were visualized angiographically. Of these, 136/3001 (4.5%) were 
localized distally to occluded coronary segments and supplied by collateral pathways thus were 
excluded from the analysis. There remained 2865 coronary segments, of which 282/2865 (9.8%) 
harboured ≥50% stenoses. Among the lesions associated with ≥50% stenosis, 89/282 (31.6%) 
were in the RCA, 110/282 (39%) in the LAD, 79/282 (29%) in the LCx, and 4/282 (1.4%) in the LM 
(p <0.001). 
 
Total calcium score and frequency of stenosis anywhere in the coronary tree (patient level) 
 
In the training set, the median (interquartile range) total calcium score at patient level was 198.10 
(10.65 - 557.40). The frequency of at least one coronary stenosis at the patient level increased 
proportionally with increasing total calcium score (p-value <0.001). In patients with a total Agatston 
calcium score in the range 0-10, 5/50 (10%) patients had at least one significant stenosis. In 
patients with a total calcium score in the range 11-100, 20/32 (62.5%) patients had at least one 
significant stenosis. In patients with a total calcium score in the range 101-400, 45/59 (76.3%) 
patients had at least one significant stenosis. In patients with a total calcium score >400, 56/60 
(93.3%) had at least one significant stenosis. The AUCs of total Agatston score for the detection of 
≥50% coronary stenosis at the patient level was 0.851 (CI: 0.681-0.900). The odds ratio (OR) for 
≥50% stenosis anywhere in the coronary tree (patient level) was approximately 1.9-fold greater (p 
<0.001) for each unit of natural log of total calcium score (OR=1.908; CI: 1.664-2.375). 
 
Segmental calcium score (SCS)  
 
In the training set, the range in SCS was 0-1370. The median (interquartile range) was 0 (0 - 6.65). 
There were 1735/2865 (60.6%) segments which did not show any detectable calcification (SCS = 
0). Of these, 68/1735 (3.9%) harboured a ≥50% stenosis. 
 
Calcification morphology  
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In the training set, there were 431/2865 (15%) spotty calcifications, 325/2865 (11.3%) wide 
calcifications, and 374/2875 (13.1%) diffuse calcifications.  
 
Frequency of significant stenoses  
 
The frequency of coronary stenosis increased proportionally with increasing SCS (Figure 4, left 
column), and from spotty, to wide, to diffuse morphology (all p-values <0.01). The frequency of 
significant stenoses associated with SCS and morphology in men and women according to age is 
given in Table 3. The AUCs for the detection of ≥50% coronary stenosis were 0.739 (CI: 0.706-
0.771) for SCS, and 0.738 (CI: 0.706-0.771) for calcification morphology (Figure 4, right column).  
 
Univariable analysis (Table 4) 
 
The odds ratio (OR) for ≥50% stenosis was approximately 1.7-fold (p = 0.005) greater for patients 
with typical chest pain and 1.6-fold (p = 0.023) greater for patients with unstable angina or non-ST 
elevation myocardial infarction (acute coronary syndrome). For patients with dyslipidemia, the OR 
was increased 2.6-fold (p <0.001), and for patients with a prior myocardial infarction the OR was 
increased 2.5-fold (p<0.001). With distal segments as comparator, the OR for ≥50% stenosis was 
approximately 1.6-fold (p<0.001) greater for middle segments, and 1.8-fold (p=0.001) greater for 
proximal segments. With the RCA as comparator, the OR was approximately 0.7-fold (p = 0.039) 
smaller for the LCx, and 0.2-fold (p <0.001) smaller for the LM; the OR’s for the RCA and LAD 
were similar. For each unit of natural log of SCS, the OR of ≥50% stenosis was 1.5-fold (p <0.001) 
greater. The presence of spotty calcifications had an OR for stenosis approximately 2.7-fold (p 
<0.001) greater than the absence of calcification, wide calcifications approximately 4.3-fold (p 
<0.001) greater, and diffuse calcifications approximately 9.1-fold (p <0.001) greater than the 
absence of calcification. 
 
Multivariable analysis (Table 5) 
 
In a GEE model, the OR for coronary stenosis was approximately 1.8-fold greater (p = 0.006) in 
patients with typical chest pain, 2-fold (p = 0.014) greater in patients with acute coronary 
syndrome, and 2-fold greater (p <0.001) in patients with prior myocardial infarction. The presence 
of spotty calcifications had an OR for stenosis approximately 2.3-fold (p <0.001) greater than the 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
absence of calcification, wide calcifications approximately 2.7-fold (p <0.001) greater, and diffuse 
calcifications approximately 4.6-fold (p <0.001) greater than the absence of calcification. With distal 
segments as comparator, each unit of natural log of SCS in middle segments corresponded to an 
OR approximately 1.2-fold (p <0.001) greater; in proximal segments this corresponded to an OR 
1.1-fold greater (p = 0.021). The LM coronary artery had an OR for stenosis approximately 0.2-fold 
(p = 0.001) smaller than the RCA, whereas the remaining coronary vessels were similar. 
 
Prediction score  
 
Based on the coefficients (multiplied by 100) of the final GEE model (Table 5), a score for the 
prediction of the probability of ≥50% stenosis in a given segment (P-score) was calculated as 
follows: 
P-score = 12*ln(SCS) (if proximal) + 17*ln(SCS) (if middle) + 83 (if spotty) + 99 (if wide) + 
153 (if diffuse) + 56 (if typical chest pain) + 69 (if acute coronary syndrome) + 68 (if prior 
myocardial infarction) -178 (if LM) -362 
The probability of ≥50% coronary stenosis increased with the extent (i.e., SCS, morphology) of 
coronary calcification. This probability was related to the P-score through the following equation: 
Probability (≥50% stenosis) = 1 / [1 + exp ( - P-score) ]  
 
Training set and test set (Figure 5) 
 
The prediction model showed a good diagnostic performance when validated in the test set. The 
AUC in the test set was 0.786 (CI: 0.757-0.814). This value was similar to the AUC in the training 
set that was 0.795 (CI: 0.770-0.819) showing a consistent performance. The Youden’s index in the 
training set gave an optimal probability threshold equal to or greater than 9.2%, which yielded 
sensitivity and specificity of 0.752 and 0.712, respectively. In the test set, the optimal probability 
threshold was equal to or greater than 6.8%, which yielded sensitivity and specificity of 0.748 and 
0.689, respectively. 
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Discussion 
Summary of findings 
 
The probability of ≥50% diameter stenosis increased with segmental calcium score (SCS), and 
from the spotty, to the wide, to the diffuse calcification morphology (Figure 4, left column), in 
keeping with findings by Lau et al. (16) and Kajinami et al. (14). For both SCS and calcification 
morphology the use of a high-specificity threshold was associated with a much lower sensitivity, 
and a high-sensitivity threshold was associated with a much lower specificity (Figure 4, right 
column), implying that SCS and calcification morphology if used per se were rather crude 
predictors of ≥50% stenosis. The compensatory enlargement of atherosclerotic coronary arteries 
(positive vessel wall remodeling) may explain this finding (17). By combining patient’s symptoms, 
clinical history and lesion location within the coronary tree, the predictive value of SCS and 
calcification morphology could be improved. We developed a multivariable prediction model 
based on segmental calcium score (SCS), calcification morphology, the patient’s symptoms 
and clinical history to predict the probability of ≥50% diameter stenosis in the same 
coronary segment. The prediction model was tested in a test sample not used for the 
development of the formula and revealed consistent performance.  
 
Clinical implications  
The total Agatston calcium score is a sensitive predictor of coronary stenosis anywhere in the 
coronary tree when a low positivity cut-off is used (94% sensitivity with a cut-off of Agatston score 
greater than 0), but with a poor specificity (47% specificity) (2). On the other hand, if a higher cut-
off is chosen, coronary calcium has better specificity at the expense of sensitivity.  
 
There is a weak relationship between intermediate calcium scores (e.g., between 100 and 399) 
and associated stenosis. CCTA can partly overcome this weakness (18). The interpretation of 
CCTA however can be challenged by focal bulky calcifications. Bulky calcifications can be 
expected in 10% of coronary segments in patients with intermediate pre-test likelihood of coronary 
artery disease, and of these one in four are associated with significant stenoses (19). Bulky 
calcifications typically lead to overestimation of lesion severity (false positive diagnosis) (19-22) 
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related to limited spatial resolution of CCTA and the resulting visual impression known as the 
‘blooming effect’. Whether focal segmental calcifications can help predict the probability of 
underlying coronary stenosis was the research question addressed by this study.  
 
The formula described here may help estimate the probability of significant stenosis in the context 
of reading CCTA in a patient with focal bulky calcifications. Whether or not further action should be 
taken - either ordering a further diagnostic test or initiating aggressive medical therapy - will not 
depend exclusively on the result of the prediction model, but rather on the global patient 
assessment. For instance, in a patient with suspected high-risk coronary artery disease (defined as 
2-vessel disease involving the LAD, 3-vessel disease or involvement of the LM) further testing and 
intention to treat may be the first option, as these patients would benefit from revascularization (23, 
24). On the other hand, in a patient with low-risk coronary artery disease (e.g. 1-vessel disease 
involving a non-prognostic vessel) aggressive medical treatment may be the first option. 
 
The diagnostic performance of the prediction model in the test sample (AUC = 0.786) was worse 
than that of patient-level Agatston calcium score (AUC = 0.851). However, a direct comparison 
does not make sense because the total Agatston score is predictive of stenosis anywhere in the 
coronary tree at the patient level, whereas the rationale of this prediction model is at segmental or 
lesion level, not at the patient level. The prediction model may help in a subset of patients with 
intermediate total Agatston calcium scores (100-399) and one or two bulky calcified plaques that 
challenge CCTA interpretation. 
 
Sharp reconstruction kernels partially compensate for the blooming effect, however this comes at 
the expense of increased image noise. Deconvolution filters require long computational times and 
have not been validated in clinical practice (25). Dual-energy scan techniques allow the acquisition 
of separate low- and high-energy images which are then synthesized to cancel high-density 
structures such as calcifications (26, 27). Compared to the conventional (single-energy) scan 
technique, these approaches are characterised by roughly double temporal resolution or spatial 
resolution, hence the added value for coronary artery imaging in patients remains uncertain. The 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
possibility of obtaining virtual non-contrast images from a single contrast-enhanced CCTA (28) 
may obviate the need to perform a non-enhanced scan prior to CCTA. Iterative reconstruction 
algorithms can reduce radiation exposure to patients without decreasing overall image quality in 
coronary calcium scoring (29) and CCTA (30), however their effect on the diagnostic performance 
of CCTA in severely calcified coronary arteries has not been firmly established.  
 
Limitations 
The Agatston calcium score is not a physical measurement of calcification (11). There was 
however a very high correlation between the Agatston and the volume/mass scores. SCS does not 
include non-calcified plaque. The training set and test set included two groups of consecutive 
patients. Small differences between groups may explain the slightly poorer fitting of the model on 
the test set compared to the training set. The test set had less patients with typical chest pain and 
more patients with atypical chest pain. The test set may thus represent a slightly more challenging 
patient group. The reported results are therefore a conservative estimate of the prediction model’s 
performance. Further research may be warranted to define in which patient population the analysis 
of SCS additional to CCTA may be most beneficial to improve diagnostic performance. 
 
Future developments 
The semi-automated quantification of coronary plaque burden and components (calcified and non-
calcified) may represent a more accurate approach for the characterisation of coronary artery 
plaques (31-34). These methods however require time-intensive manual input, as opposed to the 
quick method described here. The feasibility of stress myocardial CT perfusion imaging has been 
demonstrated recently (35-40) as capable of adding functional information on the haemodynamic 
significance of coronary stenoses. However, CT perfusion imaging requires additional patient 
radiation exposure, contrast administration and the administration of a pharmacological stress 
agent. The possibility of a CT-derived fractional flow reserve measurement based on 
computational fluid dynamics modelling, albeit computationally difficult and time-consuming, has 
also been shown with very promising results (41). The utility of computational FFR in heavily 
calcified coronary vessels (Agatston score >400), however, remains uncertain. 
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 Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Classification of calcification morphology on non-enhanced CT 
images. Modified from Kajinami et al. (14). 
 
Calcification morphology Lesion width a Lesion length b 
Diffuse ≥2/3 of coronary diameter ≥3/2 of coronary diameter 
  
Wide 
  
≥2/3 of coronary diameter <3/2 of coronary diameter 
or 
<2/3 of coronary diameter ≥3/2 of coronary diameter 
Spotty <2/3 of coronary diameter <3/2 of coronary diameter 
None Undetectable Undetectable 
a Extent of calcification perpendicular to the longitudinal direction of the vessel 
b Extent of lesion in the longitudinal direction of the vessel 
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Table 2. Baseline characteristics.  
 
   
Characteristic 
Training 
sample 
Test 
sample 
p-value e 
No. of patients   201 201 - 
Age    
Mean age (sd) a (years) 59 (12) 60 (10) 0.52 f 
Age range 21-87 35-80 - 
Age groups: no. (%) - - 0.81 
≤50 38/201 (19%) 33/201 (17%) - 
51-60 79/201 (39%) 80/201 (40%) - 
61-70 50/201 (25%) 57/201 (28%) - 
>70 34/201 (17%) 31/201 (15%) - 
Men / Women: no. (%) 142 (71%) / 59 (29%) 137 (68%) / 64 (32%) 0.59 
    
Patient clinical presentation: no. (%)    
Typical chest pain b 97/201 (48%) 57/201 (28%) <0.001 
Atypical chest pain c 71/201 (35%) 76/201 (38%) 0.61 
Acute coronary syndrome d 33/201 (17%) 68/201 (34%) <0.001 
    
Cardiovascular risk factors: no. (%)     
Obesity (Body Mass Index ≥30 Kg/m2)  48/201 (24%) 50/201 (25%) 0.84 
Smoking (current or past) 63/201 (31%) 66/201 (33%) 0.75 
Hypertension (blood pressure ≥140/90 mmHg, or on 
anti-hypertension medication) 
106/201 (53%) 110/201 (55%) 0.69 
Dyslipidemia (serum cholesterol >200 mg/dL or 5.18 
mmol/L)  
136/201 (68%) 100/201 (50%) <0.001 
Diabetes mellitus (plasma glucose ≥126 mg/dL or 7.0 
mmol/L) 
25/201 (12%) 26/201 (13%) 0.88 
Family history (presence of CAD in a first-degree 
female [<65 years] or male [<55 years] relative) 
90/201 (45%) 106/201 (53%) 0.11 
Prior myocardial infarction 43/201 (21%) 21/201 (11%) 0.003 
    
Medication before MSCT and heart rate    
Beta-blockers: no. (%) 142/201 (71%) 135/201 (67%) 0.11 
Mean heart rate during scan (sd) a (beats/min.) 58 (11) 60 (8) 0.77 
    
Total calcium score (Agatston; patient level)    
Range 0-3839 0-3394 - 
Mean (sd) a 450.37 (661.23) 346.60 (492.02) 0.70 f 
Median (IQ) g 198.10 (10.65 - 557.40) 214.70 (14.70 - 443.80) 1.00 h 
Calcium score groups: no. (%) - - 0.79 
0-10 50/201 (25%) 47/201 (23%) - 
11-100 32/201 (16%) 32/201 (16%) - 
101-400 59/201 (29%) 68/201 (34%) - 
>400 60/201 (30%) 54/201 (27%) - 
 
a standard deviation; b retrosternal pain occurring with exercise, relieved by rest and by administration of nitrates; c any 2 or 1 features of 
typical chest pain; d unstable angina or non-ST elevation myocardial infarction; e Chi squared test unless otherwise specified; f Mann-
Whitney U test; g interquartile range; h independent samples median test. 
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Table 3. Frequency of significant stenoses in relation to SCS ranges and morphology (in men and 
women according to age). 
 
 
SCS   Calcification morphology  
 
0-10 11-50 51-100 >100 p-value*  none spotty wide diffuse p-value* 
Men            
≤50 
16/384  
(4.2%) 
2/17 
 (11.8%) 
0/2 
 (0%) 
1/4 
(25%) 
0.114  
11/328 
 (3.4%) 
5/58 
 (8.6%) 
1/13 
 (7.7%) 
2/8 
 (25%) 
0.012 
51-60 
43/623 
 (6.9%) 
20/11 
 (18%) 
12/63 
 (19%) 
25/71  
(35.2%) 
<0.001  
20/495 
 (4%) 
20/140 
 (14.3%) 
20/113 
 (17.7%) 
40/120 
 (33.3%) 
<0.001 
61-70 
13/260  
(5%) 
6/59  
(10.2%) 
9/35 
 (25.7%) 
26/89  
(29.2%) 
<0.001  
7/198  
(3.5%) 
5/63 
 (7.9%) 
14/70 
 (20%) 
28/112 
 (25%) 
<0.001 
>70 
20/162  
(12.3%) 
8/39 
 (20.5%) 
4/36 
 (11.1%) 
15/49 
 (30.6%) 
0.016  
12/117 
 (10.3%) 
7/48 
 (14.6%) 
8/57  
(14%) 
20/64 
 (31.3%) 
0.003 
Women            
≤50 
4/139  
(2.9%) 
0/6 
 (0%) 
0/2  
(0%) 
value not 
observed 0.888  
3/130  
(2.3%) 
1/13 
 (7.7%) 
0/3 
 (0%) 
0/1 
 (0%) 
0.703 
51-60 
3/234 
 (1.3%) 
0/10 
 (0%) 
2/99 
 (22.2%) 
3/4 
 (75%) 
<0.001  
3/211 
 (1.4%) 
0/24 
 (0%) 
2/11 
 (18.2%) 
3/11 
 (27.3%) 
<0.001 
61-70 
16/209 
 (7.7%) 
7/39 
 (17.9%) 
1/14 
 (7.1%) 
5/14 
 (35.7%) 
0.003  
8/170 
 (4.7%) 
6/48 
 (12.5%) 
5/31 
 (16.1%) 
10/27 
 (37%) 
<0.001 
>70 
7/114  
(6.1%) 
4/35 
 (11.4%) 
2/8 
 (25%) 
8/24 
 (33.3%) 
0.001  
4/86 
 (4.7%) 
5/37 
 (13.5%) 
4/27 
 (14.8%) 
8/31 
 (25.8%) 
0.014 
* Chi squared test. Significant p-values are bolded. 
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 Table 4. Univariable logistic regression models for 
the prediction of angiographically proven 
significant coronary stenosis. 
 
Characteristic Odds Ratio (95% CI) p-value* 
Age 1.032 (1.015-1.0494) <0.001 
Gender (male) 1.629 (1.086-2.445) 0.018 
Typical chest pain 1.694 (1.178-2.438) 0.005 
Atypical chest pain 0.340 (0.214-0.538) <0.001 
Acute coronary syndrome 1.625 (1.068-2.472) 0.023 
Obesity 0.986 (0.679-1.432) 0.941 
Smoking 1.069 (0.755-1.513) 0.708 
Hypertension 1.098 (0.763-1.579) 0.615 
Dyslipidemia 2.606 (1.523-4.459) <0.001 
Diabetes 0.819 (0.513-1.307) 0.402 
Family history of CAD 0.781 (0.550-1.108) 0.166 
Prior myocardial infarction 2.537 (1.776-3.623) <0.001 
Segment location**   
Distal and side branches odds ratio comparator  
Middle 2.545 (1.913-3.386) <0.001 
Proximal 1.777 (1.272-2.483) 0.001 
Vessel   
RCA odds ratio comparator  
LAD 0.995 (0.718-1.379) 0.976 
LCx 0.722 (0.529-0.984) 0.039 
LM 0.150 (0.054-0.416) <0.001 
SCS (ln) 1.500 (1.399-1.604) <0.001 
Calcification morphology   
Spotty 2.732 (1.898-3.934) <0.001 
Wide 4.269 (2.836-6.427) <0.001 
Diffuse 9.144 (6.297-13.277) <0.001 
 
*Significant p-values are bolded. 
** Proximal segments included segments 1, 5, 6, and 11. Middle 
segments included segments 2, 3, 7, and 13. Distal and side 
branches included segments 4a, 4b, 8, 9, 10, 12, 14, 15, and 16 (9, 
15). 
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Table 5. GEE logistic regression (final) model for the 
prediction of angiographically proven significant coronary 
stenosis. 
 
Model* Odds Ratio (95% CI) p-value** Coefficient 
Clinical presentation    
Typical chest pain 1.755 (1.175-2.622) 0.006 0.562 
Acute coronary syndrome 1.989 (1.151-3.439) 0.014 0.688 
Risk factors    
Prior myocardial infarction 1.982 (1.397-2.812) <0.001 0.684 
Vessel    
LM 0.169 (0.059-0.482) 0.001 -1.776 
Calcification morphology    
Spotty 2.303 (1.567-3.384) <0.001 0.834 
Wide 2.690 (1.698-4.260) <0.001 0.989 
Diffuse 4.614 (2.842-7.491) <0.001 1.529 
SCS (ln)    
If middle segment 1.189 (1.084-1.304) <0.001 0.173 
If proximal segment 1.125 (1.018-1.242) 0.021 0.117 
 
* The model Wald chi-square was 226.32 (p <0.001). 
** Only variables that retained significant p-values in the multivariable model are 
reported here. Age, gender, atypical chest pain, dyslipidemia and LCx vessel 
location had significant p-values at univariable analysis, but not at multivariable 
analysis. 
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Figure Legends 
 
Figure 1. Method for the measurement of segmental calcium score (SCS). 
 
 
 
Figure 1. Method for the measurement of segmental calcium score (SCS). 
In order to obtain a consistent anatomic classification of the coronary tree into segments, 
contrast-enhanced CCTA axial images (A) were available to the observer. The CCTA images 
were scrolled using a viewing application (syngo Viewing, Siemens, Erlangen, Germany). 
Availability of CCTA ensured the visualization of the origin of smaller side branches, especially 
when they were not calcified. These side branches might have remained undetected on the 
non-enhanced images (B, C). The visualization of the diagonal branches allowed the 
classification into segments of the left anterior descending coronary artery (LAD); the origin of 
marginal obtuse branches allowed the classification into segments of the left circumflex artery 
(LCx), and the origin of acute marginal branches allowed the classification into segments of the 
right coronary artery (RCA). CCTA was used exclusively for the correct anatomical 
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classification of coronary segments and not for SCS measurement or estimation of stenosis 
severity. SCS was measured on non-enhanced images (42). Individual coronary segments 
were labelled according to a standard 17-segment anatomical (D).  
LM = left main artery; LAD = left anterior descending artery; LCx = left circumflex; IMB = 
intermediate branch. 
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 Figure 2. Method for separation of connected calcifications in a slice. 
 
 
 
Figure 2. Method for separation of connected calcifications in a slice. 
To assign calcifications to the corresponding individual coronary artery segment, there 
needed to be separation of connected lesions in a slice (A, B). To achieve this, 
calcifications were edited manually (C) and split (D) using the ‘3D Edit’ function (C, 
insert and arrow) of the software (syngo Calcium Scoring). 
LAD = left anterior descending artery; LCx = left circumflex. 
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Figure 3. Classification of calcification morphology.  
 
 
 
Figure 3. Classification of calcification morphology.  
We applied a method validated by Kajinami et al. (14) for the classification of calcification 
morphology. Calcification morphology was classified visually as spotty (A, arrowhead), wide (B, 
arrow) and diffuse (C, gross arrow) based on the width and length of the calcification in relation 
to the coronary segment diameter (full description in Table 1). 
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 Figure 4. Segmental calcium score (SCS) and calcification morphology: frequency of 
associated significant stenoses (left column) and ROC curves (right column). 
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Figure 4. Segmental calcium score (SCS) and calcification morphology: frequency of 
associated significant stenoses (left column) and ROC curves (right column). 
The frequency of coronary stenosis (left column) increased proportionally with increasing SCS. The 
frequency of stenosis also increased from spotty, to wide, to diffuse morphology. The diagnostic 
performances of SCS and morphology in the detection of ≥50% stenosis (right column) were similar. 
Arrows and labels indicate different calcification thresholds for positivity (i.e., ≥50% coronary artery 
stenosis). 
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Figure 5. Performance of the multivariable model (ROC curves) in the training set and test set 
 
 
Training set Test set 
  
 
 
 
Figure 5. Performance of the multivariable model (ROC curves) in the training set and test set 
The Youden’s index in the training set gave an optimal probability threshold equal to or greater than 9.2%, 
which yielded sensitivity and specificity of 0.752 and 0.712, respectively. In the test set, the optimal 
probability threshold was equal to or greater than 6.8%, which yielded sensitivity and specificity of 0.748 
and 0.689, respectively.  
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